Pantalone et al.: the risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
作者信息
Bell David S H
出版信息
Acta Diabetol. 2009 Jun;46(2):155; author reply 157. doi: 10.1007/s00592-009-0106-7. Epub 2009 Mar 20.
PMID:19300899
Abstract
摘要
Zotero 插件